Screening for prenatal substance use: Development of the substance use risk profile-pregnancy scale

Obstetrics and Gynecology

Volumn 116, Issue 4, 2010, Pages 827-833

  Yonkers, Kimberly A ^a   Gotman, Nathan ^a   Kershaw, Trace ^a   Forray, Ariadna ^a   Howell, Heather B ^a   Rounsaville, Bruce J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DOMESTIC VIOLENCE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; SUBSTANCE USE RISK PROFILE PREGNANCY SCALE; VALIDATION PROCESS; CLINICAL TRIAL; COMPARATIVE STUDY; MASS SCREENING; MULTICENTER STUDY; NONPARAMETRIC TEST; PREGNANCY; STATISTICAL MODEL; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MASS SCREENING; PREGNANCY; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77957243899     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181ed8290     Document Type: Article

References (25)

1. SAMHSA. Results from the 2001 National Household Survey on Drug Abuse: volume I: summary of national findings. Report No. SMA 02-3758, NHSDA Series H-17. U.S. Department of Health and Human Services Publication. Rockville (MD): Office of Applied Studies; 2002.
2. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003; 101:374-379
3. Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007;19:578-585
4. Palmer JM, Indermaur MD, Tebes CC, Spellacy WN. Placenta increta and cocaine abuse in a grand multipara leading to a second trimester rupture of an unscarred uterus: a case report. South Med J 2008;101:834-835
5. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998;25:139-151
6. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. ACOG Committee Opinion No. 294. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;103:1021-1031
7. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989;160:863-868
8. Russell M, Martier SS, Sokol RJ, Mudar P, Jacobson S, Jacobson J. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health 1996;86:1435-1439
9. Chang G, Wilkins-Haug L, Berman S, Goetz MA, Behr H, Hiley A. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998;91:892-898
10. Chasnoff IJ, Neuman K, Thornton C, Callaghan MA. Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol 2001;184: 752-758
11. Chasnoff IJ, McGourty RF, Bailey GW, Hutchins E, Lightfoot SO, Pawson LL, et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005;25:368-374
12. Chasnoff IJ, Wells AM, McGourty RF, Bailey LK. Validation of the 4P's Plus screen for substance use in pregnancy. J Perinatol 2007;27:744-748
13. McLellan AT, Kushner H, Metzger D. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9: 199-213.
14. Zhang HP, Singer B. Recursive partitioning in the health sciences. New York (NY): Springer-Verlag; 1999.
15. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172-181
16. Burnham K, Anderson D. Model selection and multimodal inference: a practical information-theoretic approach. 2nd ed. New York (NY): Springer-Verlag; 2002.
17. Nagelkerke NJD. A note on general definition of the coefficient of determination. Biometrika 1991;78:691-692
18. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-884
19. U.S. Preventive Services Task Force. Screening for illicit drug use. Available at: http://www.ahrq.gov/clinic/uspstf/uspsdrug.htm.
20. SAMHSA. Results from the 2007 National Survey on Drug Use and Health: national findings. Rockville (MD): Office of Applied Studies; 2007. p. 1-290.
21. Roberts SC, Nuru-Jeter A. Women's perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues 2010;20:193-200.
22. Kulaga V, Pragst F, Fulga N, Koren G. Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of fetal alcohol spectrum disorders. Ther Drug Monit 2009;31:261-266
23. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 2006; 370:17-49.
24. Gilchrist LD, Hussey JM, Gillmore MR, Lohr MJ, Morrison DM. Drug use among adolescent mothers: prepregnancy to 18 months postpartum. J Adolesc Health 1996;19:337-344
25. Ebrahim SH, Luman ET, Floyd RL, Murphy CC, Bennett EM, Boyle CA. Alcohol consumption by pregnant women in the United States during 1988-1995. Obstet Gynecol 1998;92:187-192